Voluven (Hospira Inc.)


Welcome to the PulseAid listing for the Voluven drug offered from Hospira Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira Inc.
NON-PROPRIETARY NAME: HYDROXYETHYL STARCH 130/0.4
SUBSTANCE NAME: HYDROXYETHYL STARCH 130/0.4
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-06-25
END MARKETING DATE: 0000-00-00


Voluven HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVoluven from Hospira Inc.
LABELER NAME: Hospira Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(g/100mL)
START MARKETING DATE: 2010-06-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1029_4cf79958-bba6-4ab0-b970-92b80ce04439
PRODUCT NDC: 0409-1029
APPLICATION NUMBER: BN070012

Other HYDROXYETHYL STARCH 130/0.4 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira Inc.Voluven